Search results
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Zacks via Yahoo Finance· 2 days agoIn the latest trading session, Novavax (NVAX) closed at $4.33, marking a +0.93% move from the...
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
Motley Fool via Yahoo Finance· 4 days agoOther times, some corporations lag the market for good reasons: Their businesses and prospects look...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 12 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Q1 2024 Enovix Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 16 hours agoBefore we continue, let me kindly remind you that we released our first quarter 2024 shareholder letter after the market close today is available on our website at ir dot novavax< ...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 1 day agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 1 day agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
What's in the Cards for Amgen (AMGN) This Earnings Season?
Zacks via Yahoo Finance· 4 days agoVolume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is...
ESCMID 2024: Cutting-edge vaccines in development for a healthier tomorrow
Clinical Trials Arena via Yahoo Finance· 2 days agoThe R21/Matrix-M vaccine, developed by Oxford University and the Serum Institute of India,...
The path to a better tuberculosis vaccine runs through Montana
Bozeman Daily Chronicle· 6 days agoA team of Montana researchers is playing a key role in the development of a more effective vaccine...
Sweet Harmony: Neuro biotech buys Epygenix and its epilepsy meds for $35M upfront
FierceBiotech· 3 days agoHarmony Biosciences is adding a suite of epilepsy assets to its pipeline, buying Epygenix for $35 million upfront with more than $600 million in biobucks on the table. The relatively small M ...
